AI-generated summary
The authors compared low-level laser therapy with no preventive laser in 40 children with acute lymphoblastic leukemia receiving high-dose methotrexate. They report that a higher share of patients given preventive laser did not develop oral mucositis (60% vs. 25%), and that red light at 660 nm appeared better than infrared at 830 nm.
- Participants
- 40
- Who or what was studied
- Pediatric patients with acute lymphoblastic leukemia receiving high-dose methotrexate
- Wavelengths
- 660, 830 nm
- Limits stated in the abstract
- The abstract describes a small two-group study with subgroups and does not state randomization or a formal control arm, so the findings are of limited certainty.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm, 660 nm
- Power
- 100 mW
- Total energy
- 1 J, 2 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Low-level laser therapy, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.